Buy & Sell Cenovus Energy Inc (CVE) – Cenovus Energy Inc Price Today
Aura AI Summary
Key Stats
- $51.56BMarket Cap
- EnergySector
- -13.3%3M Drawdown
- $59.58BEnterprise Value
- 2.34%Dividend Yield
- 41 daysTypical Hold Time
Cenovus Energy Inc (CVE) is currently valued at a market capitalization of $51.56B, with an enterprise value of $59.58B. Over the past 52 weeks, Cenovus Energy Inc has traded between a low of $13.6 and a high of $31.8, highlighting its annual price range. Over the past three months, Cenovus Energy Inc has recorded a drawdown of -13.3%, reflecting recent price volatility. Cenovus Energy Inc offers a dividend yield of 2.34%, with the most recent dividend of $0.20 paid on 13 Mar 26. On average, investors hold Cenovus Energy Inc for approximately 41 days, indicating typical investor behavior on the platform.
About Cenovus Energy Inc
Cenovus Energy is an integrated oil company, focused on creating value through the development of its oil sands assets. The company also engages in production of conventional crude oil, natural gas liquids, and natural gas in Alberta, Canada, with refining operations in the U.S. Net upstream production averaged 472 thousand barrels of oil equivalent per day in 2020, and the company estimates that it holds 6.7 billion boe of proven and probable reserves.
Most Recent News
US government moves toward equity stakes in AI firms ahead of historic IPOs, reshaping investor ownership.
The US government is actively negotiating to take equity stakes in AI companies like OpenAI and Anthropic ahead of their planned IPOs, following a precedent set by its investment in Intel. This move aims to give the public a share in AI-driven growth...

Trulieve becomes first US cannabis stock listed on NYSE, signaling sector shift.
Trulieve Cannabis Corp. made history by becoming the first U.S. cannabis company to list on the New York Stock Exchange under the ticker TRLV. This milestone was enabled by the Trump administration's reclassification of cannabis to Schedule III for m...

BIO-key flagged by Nasdaq for late 10-Q filing, risking its Nasdaq listing status.
BIO-key International, a leader in biometric authentication, received a Nasdaq notice for failing to file its quarterly 10-Q report on time for Q1 2026. Nasdaq's notice indicates the company's compliance with listing rules is under review, and a hear...
